Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Fukuda

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 21, 2016
L/T-type calcium channel blocker reduces non-Gaussianity of heart rate variability in chronic kidney disease patients under preceding treatment with ARBMichio Fukuda, Yoshiaki Ogiyama, Ryo Sato, et al.
Nephrology (Carlton, Vic.)|May 12, 2011
Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individualsTetsuro Yoshida, Kimihiko Kato, Hideki Horibe, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 11, 2016
Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney diseaseDaisuke Fuwa, Michio Fukuda, Yoshiaki Ogiyama, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 28, 2019
The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockersMichio Fukuda, Yukako Isobe-Sasaki, Ryo Sato, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 6, 2005
Circadian blood pressure rhythm is disturbed by nephrectomyNorihiko Goto, Kazuharu Uchida, Kunio Morozumi, et al.
American Journal of Physiology. Renal Physiology|August 26, 2011
Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorptionMichio Fukuda, Tamaki Wakamatsu-Yamanaka, Masashi Mizuno, et al.
Journal of the American Society of Hypertension : JASH|September 6, 2011
Is salt intake an independent risk factor of stroke mortality? Demographic analysis by regions in JapanTatsuya Tomonari, Michio Fukuda, Toshiyuki Miura, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 8, 2013
Circadian rhythm of urinary potassium excretion during treatment with an angiotensin receptor blockerYoshiaki Ogiyama, Toshiyuki Miura, Shuichi Watanabe, et al.
Journal of Medical Genetics|March 30, 2013
Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association studyYoshiji Yamada, Tamotsu Nishida, Sahoko Ichihara, et al.
Clinical Transplantation|June 26, 2003
A case report of a renal transplant recipient developing chronic glomerular rejection with a weak antibody against anti-donor T-cell, only detected by flow-cytometry crossmatchAsami Takeda, Kazuharu Uchida, Toshihito Haba, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 21, 2016
L/T-type calcium channel blocker reduces non-Gaussianity of heart rate variability in chronic kidney disease patients under preceding treatment with ARBMichio Fukuda, Yoshiaki Ogiyama, Ryo Sato, et al.
Nephrology (Carlton, Vic.)|May 12, 2011
Association of a genetic variant of BTN2A1 with chronic kidney disease in Japanese individualsTetsuro Yoshida, Kimihiko Kato, Hideki Horibe, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|June 11, 2016
Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney diseaseDaisuke Fuwa, Michio Fukuda, Yoshiaki Ogiyama, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 28, 2019
The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockersMichio Fukuda, Yukako Isobe-Sasaki, Ryo Sato, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 6, 2005
Circadian blood pressure rhythm is disturbed by nephrectomyNorihiko Goto, Kazuharu Uchida, Kunio Morozumi, et al.
American Journal of Physiology. Renal Physiology|August 26, 2011
Angiotensin receptor blockers shift the circadian rhythm of blood pressure by suppressing tubular sodium reabsorptionMichio Fukuda, Tamaki Wakamatsu-Yamanaka, Masashi Mizuno, et al.
Journal of the American Society of Hypertension : JASH|September 6, 2011
Is salt intake an independent risk factor of stroke mortality? Demographic analysis by regions in JapanTatsuya Tomonari, Michio Fukuda, Toshiyuki Miura, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|February 8, 2013
Circadian rhythm of urinary potassium excretion during treatment with an angiotensin receptor blockerYoshiaki Ogiyama, Toshiyuki Miura, Shuichi Watanabe, et al.
Journal of Medical Genetics|March 30, 2013
Identification of chromosome 3q28 and ALPK1 as susceptibility loci for chronic kidney disease in Japanese individuals by a genome-wide association studyYoshiji Yamada, Tamotsu Nishida, Sahoko Ichihara, et al.
Clinical Transplantation|June 26, 2003
A case report of a renal transplant recipient developing chronic glomerular rejection with a weak antibody against anti-donor T-cell, only detected by flow-cytometry crossmatchAsami Takeda, Kazuharu Uchida, Toshihito Haba, et al.
Pageof 6